CoChat

A Meta-Analysis of Placebo-Controlled Clinical Trials Assessing the Efficacy and Safety of Incretin-Based Medications in Patients with Type 2 Diabetes

Fakhoury, Walid K.H., LeReun, Corinne, Wright, Donna · 2010 · Pharmacology
Cited by 110

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Aims: A systematic review of the literature, in combination with a meta-analysis of randomized controlled trials comparing treatments with placebo, was conducted to provide an update on the clinical efficacy and safety of incretin-based medications in adult patients with type 2 diabetes. Methods: A literature search (2000–2009) identified 38 placebo-controlled trials (phase II or later – parallel design) comparing exenatide (n = 8), liraglutide (n = 7), vildagliptin (n = 11) and sitagliptin (n = 12) with placebo. Outcomes were change from baseline in HbA 1c and in weight, and the number of patient-reported hypoglycemic episodes. HbA 1c and weight outcomes were analyzed as weighted mean differences (WMD), and the number of hypoglycemic episodes as relative risks (RR). Results: Patients receiving liraglutide showed greater reduction in HbA 1c in comparison to placebo (WMD = –1.03, 95% confidence interval, CI = –1.16 to –0.90, p < 0.001) than those on sitagliptin (WMD = –0.79, 95% CI = –0.93 to –0.65, p < 0.001), exenatide (WMD = –0.75, 95% CI = –0.83 to –0.67, p < 0.001) or vildagliptin (WMD = –0.67, 95% CI = –0.83 to –0.52, p < 0.001). Weight was statistically significantly negatively associated with exenatide (WMD = –1.10, 95% CI = –1.32 to –0.87, p < 0.001) and positively associated with sitagliptin (WMD = 0.60, 95% CI = 0.33–0.87, p < 0.001) and vildagliptin (WMD = 0.56, 95% CI = 0.27–0.84, p < 0.001). The number of patient-reported hypoglycemic episodes was statistically significantly associated with the use of sitagliptin (RR = 2.56, 95% CI = 1.23–5.33, p = 0.01) and exenatide (RR = 2.40, 95% CI = 1.30–4.11, p = 0.002). Conclusion: Incretin-based therapies are effective in glycemic control and also offer other advantages such as weight loss (exenatide and liraglutide). This may have an important impact on patient adherence to medication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000314690

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 110

Metadata

Authors
Fakhoury, W. K. H., LeReun, C., & Wright, D.
Venue
Pharmacology
Publisher
S. Karger AG
Published
2010
Volume
86
Issue
1
Pages
44-57
ISSN
  • 0031-7012 (ISSN-L)
  • 1423-0313
OpenAlex
W2058468402
Cited by
110
References
11
FWCI
2.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Meta-Analysis of Placebo-Controlled Clinical Trials Assessing the Efficacy and Safety of Incretin-Based Medications in Patients with Type 2 Diabetes. https://app.cochat.ai/papers/10.1159/000314690
The paper
Fakhoury, W. K. H., LeReun, C., & Wright, D. (2010). A Meta-Analysis of Placebo-Controlled Clinical Trials Assessing the Efficacy and Safety of Incretin-Based Medications in Patients with Type 2 Diabetes. Pharmacology. https://doi.org/10.1159/000314690

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.